Nimbus Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nimbus Therapeutics - overview
Established
2009
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Founded in 2009 and based in Massachusetts, US, Nimbus Discovery, Inc. operates as a biotechnology company that develops pharmaceutical solutions by utilizing computational chemistry. Bruce Booth and Ramy Farid co-founded the company, and Jeb Keiper is the current CEO. In July 2021, Nimbus Discovery, Inc.
raised USD 105 million in venture funding from BVF Partners L. P. , RA Capital Management, Atlas Venture, Access Biotechnology, Commodore Capital, Logos Capital, and Surveyor Capital. The company offers a computational technology-driven paradigm intended to design challenging target medicines and transform drug development for novel diseases such as metabolic diseases, cancer, and immune-inflammatory disorders.
The company also designs novel small molecule candidates, enabling physicians to use such medicine to treat various metabolic diseases. Nimbus Discovery, Inc. will use the July 2021 funding to support a human study of the company’s HPK1 inhibitor candidate in cancer patients with solid tumors, which will begin later this year, and will accelerate preclinical programs against multiple targets in oncology and immunology. The company expects to initiate IND-enabling studies on two novel agents in 2022.
Current Investors
Atlas Venture, Lilly Ventures, SR One
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Bioinformatics, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.nimbustx.com
Total Amount Raised
Subscriber access only
Nimbus Therapeutics - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LP Direct | Completed | Nimbus Lakshmi, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.